FDA Panel Backs Return Of MS Drug (CBS News)
A Food and Drug Administration panel voted unanimously to let Tysabri, a drug used to treat multiple sclerosis, return to the market. Tysabri was pulled because of dangerous side effects. Advisers are debating some controls on who can use the drug.